Last reviewed · How we verify

General Anesthesia: Propofol

Etienne Xavier Keller · FDA-approved active Small molecule Quality 2/100

General Anesthesia: Propofol is a Small molecule drug developed by Etienne Xavier Keller. It is currently FDA-approved.

At a glance

Generic nameGeneral Anesthesia: Propofol
SponsorEtienne Xavier Keller
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about General Anesthesia: Propofol

What is General Anesthesia: Propofol?

General Anesthesia: Propofol is a Small molecule drug developed by Etienne Xavier Keller.

Who makes General Anesthesia: Propofol?

General Anesthesia: Propofol is developed and marketed by Etienne Xavier Keller (see full Etienne Xavier Keller pipeline at /company/etienne-xavier-keller).

What development phase is General Anesthesia: Propofol in?

General Anesthesia: Propofol is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing